Market revenue in 2023 | USD 3,100.2 million |
Market revenue in 2030 | USD 5,874.8 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Drug Eluting Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.13% in 2023. Horizon Databook has segmented the Spain drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of lifestyle-related diseases, such as hypertension and stress-related disorders, is increasing in Spain due to changing lifestyles & dietary habits. This trend necessitates more convenient and user-friendly drug delivery methods, and drug-device combination products offer an attractive option due to their noninvasive nature.
These products provide patients with a discreet and comfortable way of administering medications, aligning with evolving preferences for convenient & minimally invasive treatment options. According to an NIH report, hypertension was found in 42.6% of the Spanish adult population aged over 18 and was more common among men (49.9%) than women (37.1%).
Horizon Databook provides a detailed overview of country-level data and insights on the Spain drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Spain drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account